These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26408610)

  • 1. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease.
    Bornholz B; Benninghaus T; Reinke Y; Felix SB; Roggenbuck D; Jahns-Boivin V; Jahns R; Boege F
    Clin Chem Lab Med; 2016 Apr; 54(4):683-91. PubMed ID: 26408610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanodiscs Incorporating Native β1 Adrenergic Receptor as a Novel Approach for the Detection of Pathological Autoantibodies in Patients with Dilated Cardiomyopathy.
    Sun R; Mak S; Haschemi J; Horn P; Boege F; Luppa PB
    J Appl Lab Med; 2019 Nov; 4(3):391-403. PubMed ID: 31659076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA.
    Holthoff HP; Zeibig S; Jahns-Boivin V; Bauer J; Lohse MJ; Kääb S; Clauss S; Jahns R; Schlipp A; Münch G; Ungerer M
    Circ Res; 2012 Aug; 111(6):675-84. PubMed ID: 22811559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease.
    Bornholz B; Roggenbuck D; Jahns R; Boege F
    Autoimmun Rev; 2014 Sep; 13(9):954-62. PubMed ID: 25149394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.
    Nagatomo Y; Li D; Kirsop J; Borowski A; Thakur A; Tang WH
    J Card Fail; 2016 Jun; 22(6):417-22. PubMed ID: 26997620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
    Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK
    Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor.
    Buvall L; Bollano E; Chen J; Shultze W; Fu M
    Clin Exp Immunol; 2006 Feb; 143(2):209-15. PubMed ID: 16412044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are autoantibodies against the beta1-adrenergic receptor markers for dilated cardiomyopathy?
    Arndt-Marić R; Nägele H; Schewe G; Kromminga A
    Clin Lab; 2010; 56(11-12):519-26. PubMed ID: 21141435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β
    Nagatomo Y; McNamara DM; Alexis JD; Cooper LT; Dec GW; Pauly DF; Sheppard R; Starling RC; Tang WH;
    J Am Coll Cardiol; 2017 Feb; 69(8):968-977. PubMed ID: 28231950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of DCM-associated β1-adrenergic receptor autoantibodies requires functional readouts or native human β1-receptors as targets.
    Bornholz B; Hanzen B; Reinke Y; Felix SB; Jahns R; Schimke I; Wallukat G; Boege F
    Int J Cardiol; 2016 Jan; 202():728-30. PubMed ID: 26461921
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy.
    Patel PA; Hernandez AF
    Eur J Heart Fail; 2013 Jul; 15(7):724-9. PubMed ID: 23639780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells.
    Tutor AS; Penela P; Mayor F
    Cardiovasc Res; 2007 Oct; 76(1):51-60. PubMed ID: 17628514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of cross-reacting antibodies anti-β1AR and anti-B13 in advanced stages of Chagas heart disease.
    Rodeles LM; Vicco MH; Bontempi IA; Siano A; Tonarelli G; Bottasso OA; Arias P; Marcipar IS
    Trop Med Int Health; 2016 Dec; 21(12):1545-1551. PubMed ID: 27699992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody directed against an autoimmune epitope on the human beta1-adrenergic receptor recognized in idiopathic dilated cardiomyopathy.
    Mobini R; Fu M; Wallukat G; Magnusson Y; Hjalmarson A; Hoebeke J
    Hybridoma; 2000 Apr; 19(2):135-42. PubMed ID: 10868793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevant effects of beta
    Boivin-Jahns V; Jahns R; Boege F
    Front Biosci (Landmark Ed); 2018 Jun; 23(11):2146-2156. PubMed ID: 29772551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.
    Jahns R; Boivin V; Siegmund C; Inselmann G; Lohse MJ; Boege F
    Circulation; 1999 Feb; 99(5):649-54. PubMed ID: 9950662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure.
    Nikolaev VO; Boivin V; Störk S; Angermann CE; Ertl G; Lohse MJ; Jahns R
    J Am Coll Cardiol; 2007 Jul; 50(5):423-31. PubMed ID: 17662395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.
    Bornholz B; Weidtkamp-Peters S; Schmitmeier S; Seidel CA; Herda LR; Felix SB; Lemoine H; Hescheler J; Nguemo F; Schäfer C; Christensen MO; Mielke C; Boege F
    Cardiovasc Res; 2013 Mar; 97(3):472-80. PubMed ID: 23208588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody.
    Larsson L; Mobini R; Aukrust P; Gullestad L; Wallukat G; Waagstein F; Fu M
    Autoimmunity; 2004; 37(6-7):489-93. PubMed ID: 15621576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating autoantibodies to the β1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism.
    Galloway A; Li H; Vanderlinde-Wood M; Khan M; Benbrook A; Liles C; Zillner C; Rao V; Cunningham MW; Yu X; Kem DC
    Endocrine; 2015 Jun; 49(2):457-63. PubMed ID: 25500789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.